Eyetracking-enhanced VEP for nystagmus
Eyetracking-enhanced VEP for nystagmus
Visual evoked potential (VEP) testing is an essential first stage in the diagnostic workup of patients with infantile nystagmus (IN). VEPs are an important factor in the diagnosis of albinism, which accompanies IN in ~28% of cases, as well as chiasmal, optic nerve and neurometabolic disease that can all present with IN. VEPs are also used to assess prognostic visual ability in cases of retinal dystrophy and optic nerve disease. Despite being used regularly in those with IN, VEP testing requires patients to keep the eyes still; something that people with IN naturally cannot do. Fixation instability during VEP testing is believed to reduce VEP signal amplitude, and as a result, the reliability of VEP may be reduced in one of the patient groups that needs it the most. This study investigates whether VEP signal quality (amplitude) can be improved in people with IN, by triggering acquisition only during the foveating (slow) periods of the nystagmus waveform.
Self, James
0f6efc58-ae24-4667-b8d6-6fafa849e389
Dunn, Matt
fab9d2ea-2428-4c2d-8c72-7c07515b7dfc
Carter, Perry
b330105f-f4ee-4cbf-88bb-d2c97b9aa126
Shawkat, Fatima
10bffac1-9300-43f6-832e-11c0f1feca36
Osborne, Daniel
d42306f4-65ba-4e3f-8402-6663f3963ee7
7 June 2020
Self, James
0f6efc58-ae24-4667-b8d6-6fafa849e389
Dunn, Matt
fab9d2ea-2428-4c2d-8c72-7c07515b7dfc
Carter, Perry
b330105f-f4ee-4cbf-88bb-d2c97b9aa126
Shawkat, Fatima
10bffac1-9300-43f6-832e-11c0f1feca36
Osborne, Daniel
d42306f4-65ba-4e3f-8402-6663f3963ee7
Self, James, Dunn, Matt, Carter, Perry, Shawkat, Fatima and Osborne, Daniel
(2020)
Eyetracking-enhanced VEP for nystagmus.
ARVO meeting: ARVO meeting, Online.
15 Jun 2017 - 20 Jun 2020 .
Record type:
Conference or Workshop Item
(Other)
Abstract
Visual evoked potential (VEP) testing is an essential first stage in the diagnostic workup of patients with infantile nystagmus (IN). VEPs are an important factor in the diagnosis of albinism, which accompanies IN in ~28% of cases, as well as chiasmal, optic nerve and neurometabolic disease that can all present with IN. VEPs are also used to assess prognostic visual ability in cases of retinal dystrophy and optic nerve disease. Despite being used regularly in those with IN, VEP testing requires patients to keep the eyes still; something that people with IN naturally cannot do. Fixation instability during VEP testing is believed to reduce VEP signal amplitude, and as a result, the reliability of VEP may be reduced in one of the patient groups that needs it the most. This study investigates whether VEP signal quality (amplitude) can be improved in people with IN, by triggering acquisition only during the foveating (slow) periods of the nystagmus waveform.
This record has no associated files available for download.
More information
Published date: 7 June 2020
Venue - Dates:
ARVO meeting: ARVO meeting, Online, 2017-06-15 - 2020-06-20
Identifiers
Local EPrints ID: 443933
URI: http://eprints.soton.ac.uk/id/eprint/443933
PURE UUID: 992cee77-9447-40ea-9ad5-bba0491ada11
Catalogue record
Date deposited: 17 Sep 2020 16:30
Last modified: 17 Mar 2024 03:04
Export record
Contributors
Author:
Matt Dunn
Author:
Perry Carter
Author:
Fatima Shawkat
Author:
Daniel Osborne
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics